Panacea Biotec launches ViLACT in India

10 Dec 2019 Evaluate

Panacea Biotec has launched a brand ViLACT in India, available in four formulations (ViLACT, ViLACT M500, ViLACT M850 and ViLACT M1000). ViLACT is used in the treatment of Uncontrolled Type 2 Diabetes Mellitus patients.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

389.80 -2.25 (-0.57%)
20-Jan-2026 12:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.80
Dr. Reddys Lab 1184.20
Cipla 1380.55
Zydus Lifesciences 876.15
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×